Human Fertilisation and Embryology Authority/Human Tissue Authority

Lord Mackay of Clashfern Excerpts

Tuesday 1st February 2011 Grand Committee

[Lord Mackay of Clashfern]

My Lords, I congratulate the noble Baroness on securing this debate at this time; it is perhaps an important interval, which we might not have expected to have but for other activities in the House. As your Lordships will know, I had the privilege of introducing the HFEA legislation all those years ago, so I feel a certain parental responsibility towards the authority that prevents me from wanting to see it perish. However, as children grow up, the needs surrounding them can change and it may well be asked whether all that the HFEA was set up to do needs to be done in quite that way now. For example, when it was set up, IVF was comparatively rare and it would be fair to say that people were somewhat afraid of it. We had the benefit of the report of the noble Baroness, Lady Warnock, suggesting what should happen.

Since that time, IVF has become a much more regularly occurring clinical process. Undoubtedly, there have been questions—for example, about the number of embryos to implant—but these processes take place in other areas as well; there are important risks in many clinical processes and we have authorities that are responsible for monitoring them. There may well be a case, therefore, for considering whether the control of the practice of IVF should continue with the HFEA. Research, too, happens in many areas. It involves important ethical issues, even in other branches of medicine and scientific research. I think that the HFEA was set up primarily from the point of view of that research and its control. Although there may be room for modification, that should continue.

I have had no direct concern with the Human Tissue Authority—I am glad to see its chair taking part in our debate—but I had the privilege of sitting on the Select Committee that looked at the draft Bill. Many questions relating to the Human Tissue Act were raised there. The answer of the then Government was: “If these are mistakes, it is too early to correct them”. I have always thought that the sooner you correct a mistake that you have made, the better. I have no particular concern about the Human Tissue Authority. Our Joint Committee raised the possibility of a degree of co-operation between the two authorities that had not until then existed, although the situation may well have improved since we completed our deliberations. However, it is absolutely clear that the committee found no basis on which these two authorities could properly be put together as a single authority. We were absolutely unanimous and strongly of that view.

Carers

Lord Mackay of Clashfern Excerpts

Wednesday 16th June 2010 Lords Chamber

[Lord Tebbit]

My Lords, would my noble friend say—

[Lord Mackay of Clashfern]

My Lords, I declare an interest as a vice-president of the Princess Royal Trust for Carers. Can the noble Lord say whether it is appropriate that carers for those who are disabled on account of substance abuse should be subject to the same disability, as it were, as the person for whom they care?

[Earl Howe]

My Lords, this is a complex question and one that my noble and learned friend will, I hope, know that we are bearing closely in mind. Those often young people who look after disabled parents are in special need, as I have said, but we recognise, too, the huge responsibility placed on parents who care for a disabled child and who often bear particular burdens. On that score, while noble Lords will be aware that the child trust fund has been abolished, the changes that we introduced in so doing include provision for more than £20 million a year, starting next year, to be spent on providing additional respite breaks for carers of severely disabled children. In passing, I pay tribute to the work of the Princess Royal Trust for Carers.